1. Zhang, Hongdian, Han, Youming, Xiao, Wanyi, Tang, Peng, Yu, Zhentao. 2023. USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1. In Cell death & disease, 14, 730. doi:10.1038/s41419-023-06259-0. https://pubmed.ncbi.nlm.nih.gov/37949874/
2. Zhou, Jiangqiao, Qiu, Tao, Wang, Tianyu, Zhang, Long, Zou, Jilin. 2019. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling. In Clinical science (London, England : 1979), 133, 335-349. doi:10.1042/CS20180959. https://pubmed.ncbi.nlm.nih.gov/30622220/
3. Hu, Chuanxiang, Zhang, Wei, Jia, Yongsheng, Hao, Chengfei, Yu, Yang. 2024. USP4 promotes PTC progression by stabilizing LDHA and activating the MAPK and AKT signaling pathway. In Aging, 16, 12850-12865. doi:10.18632/aging.206108. https://pubmed.ncbi.nlm.nih.gov/39393052/
4. Zhong, Ming, Jiang, Qi, Jin, Ronghui. 2018. USP4 expression independently predicts favorable survival in lung adenocarcinoma. In IUBMB life, 70, 670-677. doi:10.1002/iub.1755. https://pubmed.ncbi.nlm.nih.gov/29667299/
5. Zhang, Xinna, Berger, Franklin G, Yang, Jianhua, Lu, Xiongbin. 2011. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. In The EMBO journal, 30, 2177-89. doi:10.1038/emboj.2011.125. https://pubmed.ncbi.nlm.nih.gov/21522127/
6. Fan, Y-H, Yu, Y, Mao, R-F, Fu, S-B, Yang, J. 2011. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. In Cell death and differentiation, 18, 1547-60. doi:10.1038/cdd.2011.11. https://pubmed.ncbi.nlm.nih.gov/21331078/
智鼠故事 
